Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Clinical trial NCT06589440 · RECRUITING
Trial details
- NCT number
- NCT06589440
- Sponsor
- Stingray Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2027-07-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.